Physician profile
Chase E Mitchell
NPI 1841605268
$1,394.12
in general payments reported to CMS, 2019-2025
41 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $126 · 2023: $417 · 2024: $279 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $138.98 | 2023 | Iovera, Zilretta |
| Abbvie INC. | $124.26 | 2021-2023 | |
| Active Medical, LLC | $75.18 | 2024 | |
| Solventum Corporation | $61.06 | 2025 | Prevena |
| Lilly USA, LLC | $60.16 | 2021-2025 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $52.43 | 2021 | |
| Shield Therapeutics INC | $51.80 | 2023-2024 | Accrufer |
| Vericel Corporation | $47.62 | 2022-2025 | Maci |
| Smith+Nephew, INC. | $47.06 | 2024 | Multifix, Bone Anchors With Arthroscopic Delivery System |
| Dynavax Technologies Corporation | $46.40 | 2023-2024 | Heplisav-B |
| Takeda Pharmaceuticals U.S.A., INC. | $43.70 | 2021-2024 | Trintellix |
| Zimmer Biomet Holdings, INC. | $43.34 | 2022-2025 | Tapestry |
| Janssen Pharmaceuticals, INC | $39.54 | 2023-2024 | Spravato |
| Cerapedics INC. | $39.39 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Novo Nordisk INC | $32.34 | 2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $31.12 | 2023 | Wristmotion |
| Depuy Synthes Sales INC. | $27.38 | 2021 | |
| Moximed, INC | $27.22 | 2025 | Misha Knee System, Small, Left |
| Astellas Pharma US INC | $25.56 | 2024 | Veozah |
| Alafair Biosciences, INC. | $23.82 | 2025 | Versawrap |
| Endo Pharmaceuticals INC. | $23.62 | 2022 | |
| Merck Sharp & Dohme LLC | $22.36 | 2025 | Vaxelis, Gardasil 9, Rotateq |
| Stryker Corporation | $22.15 | 2025 | Gamma |
| Horizon Therapeutics Plc | $21.81 | 2023 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $20.80 | 2024 | |
| Endo USA, INC. | $18.79 | 2025 | Xiaflex |
| Seqirus USA INC | $17.28 | 2025 | Flucelvax, Fluad |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.25 | 2023 | Trulance, Xifaxan |
| Exact Sciences Corporation | $16.96 | 2025 | Cologuard Collection Kit |
| Upsher-Smith Laboratories LLC | $16.87 | 2021 | |
| Si-Bone, INC. | $15.64 | 2022 | |
| Davol INC. | $14.94 | 2024 | Arista Ah Flexitip |
| Eisai INC. | $14.88 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.61 | 2022 | |
| Orthofix Medical, INC. | $14.47 | 2023 | Physio-Stim |
| Pfizer INC. | $14.34 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.26 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $13.84 | 2023 | Shingrix, Arexvy |
| Halozyme INC | $13.81 | 2023 | |
| Inspire Medical Systems, INC. | $13.69 | 2024 | Inspire |
| Bioventus LLC | $13.39 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.